4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-24-005757
Chief Commercial Officer, MRD sold 12,991 shares at an average $3.44 ($44,629)
- Chief Commercial Officer, MRD acquired 132,979 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOBULSKY SUSAN Chief Commercial Officer, MRD | 2024-03-04 | Grant or award | +132,979 | 261,281 | D | ||
| BOBULSKY SUSAN Chief Commercial Officer, MRD | 2024-03-05 | Sale | −6,016 | $3.43 | $20,635 | 255,265 | D |
| BOBULSKY SUSAN Chief Commercial Officer, MRD | 2024-03-05 | Sale | −6,975 | $3.44 | $23,994 | 248,290 | D |
| Derivatives | |||||||
| BOBULSKY SUSAN Chief Commercial Officer, MRD | 2024-03-04 | Grant or award · Stock Option (right to buy) | +199,549 | 199,549 | D | ||
| Open-market sales · 12,991 sh · avg $3.44 · $44,629 | |||||||
Loading xslF345X05/form4.xml…